ATRC : Summary for AtriCure, Inc. - Yahoo Finance

U.S. Markets closed

AtriCure, Inc. (ATRC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
17.39-0.10 (-0.60%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close17.49
Bid13.14 x 100
Ask17.45 x 100
Day's Range17.15 - 17.74
52 Week Range13.44 - 20.40
Avg. Volume244,390
Market Cap577.88M
PE Ratio (TTM)-15.29
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire16 days ago

    CORRECTING and REPLACING AtriCure to Announce Fourth Quarter and Full Year 2016 Financial Results

    Please replace the release with the headline, AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2016, dated Feb. 3, 2017 with the following corrected version due to multiple revisions.

  • Business Wire26 days ago

    AtriCure to Present at the Leerink Partners Global Healthcare Conference

    AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced that it will present at the Leerink Partners Global Healthcare Conference at the Palace Hotel in New York City on Thursday, February 16, 2017.

  • AtriCure, Inc. – Value Analysis (NASDAQ:ATRC) : January 11, 2017
    Capital Cubelast month

    AtriCure, Inc. – Value Analysis (NASDAQ:ATRC) : January 11, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives AtriCure, Inc. a score of 28. Our analysis is based on comparing AtriCure, Inc. with the following peers – Teleflex Incorporated, Boston Scientific Corporation, Cooper Companies, Inc., Edwards Lifesciences Corporation, ABIOMED, Inc., Dextera Surgical, Inc., Medtronic plc, Stereotaxis, Inc. and Johnson & Johnson (TFX-US, BSX-US, COO-US, EW-US, ... Read more (Read more...)